Glenmede Trust’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,261
Closed -$331K 1399
2024
Q3
$331K Sell
6,261
-2,761
-31% -$146K ﹤0.01% 1066
2024
Q2
$489K Buy
9,022
+994
+12% +$53.9K ﹤0.01% 914
2024
Q1
$563K Buy
8,028
+4,210
+110% +$295K ﹤0.01% 892
2023
Q4
$319K Sell
3,818
-6,264
-62% -$523K ﹤0.01% 1018
2023
Q3
$297K Sell
10,082
-2,161
-18% -$63.7K ﹤0.01% 992
2023
Q2
$431K Hold
12,243
﹤0.01% 871
2023
Q1
$431K Sell
12,243
-823
-6% -$29K ﹤0.01% 876
2022
Q4
$599K Sell
13,066
-247
-2% -$11.3K ﹤0.01% 793
2022
Q3
$645K Sell
13,313
-5,611
-30% -$272K ﹤0.01% 755
2022
Q2
$743K Buy
18,924
+6,654
+54% +$261K ﹤0.01% 750
2022
Q1
$451K Buy
12,270
+164
+1% +$6.03K ﹤0.01% 926
2021
Q4
$551K Buy
12,106
+459
+4% +$20.9K ﹤0.01% 898
2021
Q3
$416K Buy
+11,647
New +$416K ﹤0.01% 946
2020
Q4
Sell
-982
Closed -$21K 1470
2020
Q3
$21K Buy
982
+73
+8% +$1.56K ﹤0.01% 1597
2020
Q2
$21K Buy
909
+474
+109% +$11K ﹤0.01% 1567
2020
Q1
$4K Hold
435
﹤0.01% 2710
2019
Q4
$4K Sell
435
-173
-28% -$1.59K ﹤0.01% 2710
2019
Q3
$6 Buy
608
+107
+21% +$1 ﹤0.01% 2557
2019
Q2
$5 Buy
501
+215
+75% +$2 ﹤0.01% 2617
2019
Q1
$2 Buy
286
+62
+28% ﹤0.01% 2821
2018
Q4
$1 Buy
+224
New +$1 ﹤0.01% 2873
2016
Q4
Sell
-88
Closed 2497
2016
Q3
$0 Buy
+88
New ﹤0.01% 2600
2013
Q4
Sell
-17,905
Closed -$138K 2286
2013
Q3
$138K Buy
+17,905
New +$138K ﹤0.01% 1265